PRINTER'S NO.  636

  

THE GENERAL ASSEMBLY OF PENNSYLVANIA

  

SENATE RESOLUTION

 

No.

47

Session of

2009

  

  

INTRODUCED BY LEACH, STOUT, LOGAN, ERICKSON, FONTANA, WASHINGTON, DINNIMAN, FERLO, HUGHES, WOZNIAK, PILEGGI, BOSCOLA, O'PAKE, PIPPY, COSTA, STACK, WILLIAMS, EARLL AND GREENLEAF, MARCH 10, 2009

  

  

INTRODUCED AND ADOPTED, MARCH 10, 2009  

  

  

  

A RESOLUTION

  

1

Designating the week of March 16 through 20, 2009, as "Familial

2

Dysautonomia Awareness Week" in Pennsylvania.

3

WHEREAS, Originally reported in 1949, familial dysautonomia,

4

also known as Riley-Day Syndrome, is recognized as one of

5

several hereditary sensory and autonomic neuropathies; and

6

WHEREAS, Familial dysautonomia is an autosomal recessive

7

genetic disorder that affects the autonomic and sensory nervous

8

systems; and

9

WHEREAS, Evidence of the disorder may be noted from birth,

10

although neurologic deterioration progresses with age; and

11

WHEREAS, It is estimated that one in 27 people of Ashkenazi

12

Jewish descent are carriers of the familial dysautonomia

13

mutation which is found in males and females equally; and

14

WHEREAS, Because familial dysautonomia has been noted almost

15

exclusively in Ashkenazi Jews, it is included as one of the

16

Jewish genetic diseases; and

17

WHEREAS, Current survival statistics indicate that a newborn

 


1

with familial dysautonomia has a 50% probability of reaching 40

2

years of age; and

3

WHEREAS, Familial dysautonomia affects tear production,

4

swallowing, temperature regulation and sensitivity to heat or

5

pain; and

6

WHEREAS, Other symptoms include excessive sweating, certain

7

gastrointestinal, circulatory and respiratory conditions, speech

8

and motor incoordination, poor growth and scoliosis; and

9

WHEREAS, Familial dysautonomia patients can function

10

independently in the absence of major disabilities with early

11

treatment; and

12

WHEREAS, There currently is no cure for familial

13

dysautonomia, but some available treatments can improve the

14

length and quality of life; and

15

WHEREAS, The mission is to find a cure for familial

16

dysautonomia by funding relevant research programs, to provide a

17

support network aimed at addressing the needs of patients and

18

families and to promote education and awareness programs in the

19

medical community and the public; therefore be it

20

RESOLVED, That the Senate designate the week of March 16

21

through 20, 2009, as "Familial Dysautonomia Awareness Week" in

22

Pennsylvania.

- 2 -